Market Signal Briefing

Valley National Bancorp: Poised For Growth After Transformation (Upgrade)

January 30, 2026 17:06 ET  | Source: Reflex Advanced Materials Corp.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE:RFLX) (FSE:HF2) (“Reflex” or the “Company”) is pleased to announce that it has closed its previously announced non-brokered private placement offering of units of the Company (“Units”), at a price of C$0.175 per Unit, for aggregate gross proceeds of C$199,925. Each Unit is comprised of one common share of the Company (each, a “Share”) and one Share purchase warrant (each, a “Warrant”), with each Warrant entitling the holder to acquire one Share (each, a “Warrant Share”) at a price of C$0.23 for a period of 24 months.

The Company intends to use the net proceeds raised from the Offering for working capital and general corporate purposes. All securities issued in the Offering are subject to a four month and one day hold period.

The securities issued pursuant to the Offering have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons in the absence of U.S. registration or an applicable exemption from the U.S. registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful.

About Reflex Advanced Materials Corp.

Reflex Advanced Materials Corp. is a mineral exploration company based in British Columbia. Its objective is to locate and, if warranted, develop economic mineral properties in the strategic metals and advanced materials space. It is focused on improving domestic specialty mineral infrastructure efficiencies to meet surging national demand by North American manufacturers.

For more information, please review the Company's filings available at www.sedarplus.ca and visit the Company's website at www.reflexmaterials.com.

ON BEHALF OF THE COMPANY

DJ Bowen
Interim CEO & Director

Reflex Advanced Materials Corp.
Suite 915 - 700 West Pender Street
Vancouver, BC V6C 1G8 Canada
Tel: (778) 837-7191
Email: [email protected]

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the proposed use of proceeds therefrom and the Company's business prospects, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, availability of capital, and changes in general economic, market and business conditions, and timely receipt of all necessary regulatory and other approvals. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors.

January 30, 2026 17:10 ET  | Source: Elcora Advanced Materials Corp.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

HALIFAX, Nova Scotia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V: ERA | Frankfurt: ELM0 | OTCQB: ECORF), (the "Company" or "Elcora"), is pleased to announce that it has closed a second tranche (the “Second Tranche”) of its private placement pursuant to a price reservation Form 4A (“Form 4A”) filed with the TSX Venture Exchange on December 29, 2025 (see news release dated January 23, 2026). The Company issued 10,591,666 units at a price of $0.12 per Unit for gross proceeds of approximately $1,271,000 for the Second Tranche.

As announced on January 23, 2026, the Company issued 8,158,333 units at a price of $0.12 per Unit for gross proceeds of approximately $979,000 for the first tranche (the “First Tranche”). Accordingly, upon completion of the Second Tranche, the Company has issued a combined total of 18,749,999 Units at $0.12 and raised combined total gross proceeds of approximately $2,250,000.

Pursuant to the Form 4A, the Company may issue up to 25,000,000 Units at $0.12 per unit (the “Units”) to raise total gross proceeds of up to $3,000,000 (the “Offering”).   Each Unit will consist of one (1) common share and one (1) share purchase warrant (a “Warrant”). Each Warrant will be exercisable for an additional share at a price of $0.16 for a period of twenty-four (24) months from issuance.

One of the Company’s Directors participated in the Offering and acquired 1,183,334 Units in the First Tranche and an additional 816,667 Units in the Second Tranche, for total gross proceeds of approximately $240,000. The participation by insiders in the Offering is considered to be a “related party transaction” as defined under Multilateral Instrument 61-101 (“MI 61- 101”).  The transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of the securities being issued nor the consideration being paid exceeds 25% of the Company’s market capitalization.

No finders’ fees were paid and no new insider or control person was created. The Company intends to use the net proceeds for general working capital purposes. All securities issued pursuant to the offering will be subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws. Closing of the Offering is subject to receipt of all necessary regulatory approvals and final acceptance by the TSX Venture Exchange.

About Elcora Advanced Materials Corp.

Elcora was founded in 2011 and has been structured to become a vertically integrated battery material company. Elcora can process, refine, and produce battery related minerals and metals. As part of the vertical integration strategy Elcora has developed a cost-effective process to purify high-quality battery metals and minerals that are commercially scalable. This combination means that Elcora has the tools and resources for vertical integration of the battery minerals and metals industry.

For further information please visit the company's website at:

http://www.elcoracorp.com 

For further information please contact: Troy Grant, Director, President & CEO, Elcora Advanced Materials Corp., T: +1 902 802-8847

CAUTIONARY STATEMENT:

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.  Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock Exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.  

This News Release includes certain “forward-looking statements”. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding potential mineralization and reserves, exploration results, and future plans and objectives of Elcora, are forward-looking statements that involve various risks and uncertainties.  There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.  Important factors that could cause actual results to differ materially from Elcora’s expectations are exploration risks detailed herein and from time to time in the filings made by Elcora with securities regulators.

Investors are cautioned that, except as disclosed in the filing statement prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon.

Elekta AB (publ) (EKTAY) Shareholder/Analyst Call January 30, 2026 8:00 AM EST

Company Participants

Peter Nyquist - Head of Investor Relations
Jakob Just-Bomholt - CEO & President
Christopher Busch - Chief Product & Technology Officer
Anming Gong
Ardie Ermers

Conference Call Participants

Jonathon Unwin - Barclays Bank PLC, Research Division
Veronika Dubajova - Citigroup Inc., Research Division
Richard Felton - Goldman Sachs Group, Inc., Research Division
Erik Cassel - Danske Bank A/S, Research Division
Sten Gustafsson - ABG Sundal Collier Holding ASA, Research Division
Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division
Kavya Deshpande - UBS Investment Bank, Research Division
Ludwig Germunder - Handelsbanken Capital Markets AB, Research Division

Presentation

Peter Nyquist
Head of Investor Relations

Good afternoon, everyone, and a warm welcome to today's strategy update presentation by Elekta. My name is Peter Nyquist, and I'm Head of Investor Relations at Elekta. With me here in different time zones around the world, I have Jakob, our CEO, in the studio here in Stockholm. In Cawley, just outside London, we have Christopher Busch, Chief Product and Technology Officer. And in Beijing, China, we have Anming Gong, Head of the region China. And finally, we have our Head of North America, Ardie Ermers speaking from Atlanta U.S.

So today, we will talk about 4 priorities. We call them must-win battles. The first one, Simplify, Empower and Speed. That was one we presented actually as we report our Q2 numbers. And today, we will go mere into how we established our new operating model and talk about the SEK 500 million in yearly savings that generated from that new operating model. But we will also present further 3 must-win battle. One is focused innovation; the second one is win in the U.S. and expand in China; and the third one is continuous COGS reduction.

Today, the presentation will not include any new financials. We will

Extraordinary General Meeting of Shareholders to Approve Business Combination Scheduled for February 27, 2026  

Fort Worth, TX, Jan. 30, 2026 (GLOBE NEWSWIRE) -- EQV Ventures Acquisition Corp. (NYSE: FTW) (“EQV”), a special purpose acquisition company sponsored by EQV Group, and Presidio Investment Holdings LLC (“Presidio”), a differentiated oil and gas operator focused on the optimization of mature, producing oil and natural gas assets in the United States, today announced that EQV’s registration statement on Form S-4 relating to the previously announced business combination between EQV and Presidio (the “Business Combination”) has been declared effective by the U.S. Securities and Exchange Commission (the “SEC”).

EQV will mail the definitive proxy statement/prospectus (the “Proxy Statement/Prospectus”) to shareholders of record as of the close of business on January 30, 2026. The Proxy Statement/Prospectus contains a proxy card relating to the extraordinary general meeting of EQV’s shareholders (the “Extraordinary General Meeting”).

The Extraordinary General Meeting to approve the proposed Business Combination is scheduled to be held on February 27 at 8.00 a.m. Central Time via a virtual meeting format at www.virtualshareholdermeeting.com/FTW2026SM. If the proposals at the Extraordinary General Meeting are approved, the parties anticipate that the Business Combination will close and the combined entity will trade on the New York Stock Exchange under the ticker symbol “FTW” shortly thereafter, subject to the satisfaction or waiver, as applicable, of all other closing conditions.

“Congratulations to all our stakeholders on this important milestone as we approach completion of our Business Combination. We look forward to closing the transaction and implementing our PDP-focused dividend yield acquisition platform. As we disclosed in our recent investor presentation, our backlog of potential acquisition targets has increased to $15 billion. These prospective targets align with our investment criteria, including driving dividend growth,” said Will Ulrich, Co-Founder and Co-CEO of Presidio.

Jerry Silvey, Founder and CEO of EQV, added, "We are excited to reach this critical step in bringing Presidio to the public markets. Presidio's proven track record of acquiring and optimizing producing oil and gas assets positions the company to return capital to shareholders at an attractive rate while executing its growth strategy."

Every shareholder's vote is important, regardless of the number of shares held. Accordingly, EQV requests that each shareholder complete, sign, date and return a proxy card (online or by mail) as soon as possible, which must be received no later than 11:59 p.m. Eastern Time on February 26, 2026, to ensure that the shareholder's shares will be represented at the Extraordinary General Meeting. Shareholders who hold shares in “street name” (i.e. those shareholders whose shares are held of record by a broker, bank or other nominee) should contact their broker, bank or nominee to ensure that their shares are voted.

If any EQV shareholder does not receive the Proxy Statement/Prospectus, such shareholder should (i) confirm his or her Proxy Statement/Prospectus’ status with his or her broker or (ii) contact Sodali & Co., EQV's proxy solicitor, for assistance via e-mail at [email protected] or toll-free call at (800) 662-5200. Banks and brokers can place a collect call to Sodali & Co. at (203) 658-9400.

About Presidio

Headquartered in Fort Worth, TX, Presidio is a leading operator of mature oil and gas wells across the Mid-Continent. The company is focused exclusively on optimizing existing production and generating sustainable cash flow from low-decline, producing assets. To learn more about Presidio, please visit https://bypresidio.com/.

About EQV Ventures Acquisition Corp.

EQV Ventures Acquisition Corp. (NYSE: FTW) is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. EQV’s sponsor is an affiliate of EQV Group, which was formed in 2022 and is an active acquirer and operator of proved developed producing oil and gas properties, and currently owns and operates more than 3,500 wells across 10 states.

Forward-Looking Statements

This press release includes “forward-looking statements.” These include EQV’s, Presidio Pubco Inc’s (“Pubco”), EQVR’s or Presidio’s or their management teams’ expectations, hopes, beliefs, intentions or strategies regarding the future. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “potential,” “budget,” “may,” “will,” “could,” “should,” “continue” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding Pubco’s, Presidio’s, EQVR’s and EQV’s expectations with respect to future performance, the capitalization of EQV or Pubco after giving effect to the proposed Business Combination and expectations with respect to the future performance and the success of Pubco following the consummation of the proposed Business Combination. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Pubco’s, Presidio’s, EQVR’s and EQV’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied upon by any investors as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Pubco, Presidio, EQVR and EQV. These forward-looking statements are subject to a number of risks and uncertainties, including changes in business, market, financial, political and legal conditions; benefits from hedges and expected production; the inability of the parties to successfully or timely consummate the proposed Business Combination, including the risk that any regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect Pubco or the expected benefits of the proposed Business Combination or that the approval of the shareholders of EQV is not obtained; failure to realize the anticipated benefits of the proposed Business Combination, which may be affected by, among other things, competition, the ability of Pubco to grow and manage growth profitably, maintain key relationships and retain its management and key employees; risks related to the uncertainty of the projected financial information with respect to Presidio or Pubco; risks related to Presidio’s current growth strategy; the occurrence of any event, change or other circumstances that could give rise to the termination of any definitive agreements with respect to the proposed Business Combination; the outcome of any legal proceedings that may be instituted against any of the parties to the potential Business Combination following its announcement and any definitive agreements with respect thereto; changes to the proposed structure of the proposed Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the proposed Business Combination; risks that Presidio or Pubco may not achieve their expectations; the ability to meet stock exchange listing standards following the proposed Business Combination; the risk that the proposed Business Combination disrupts the current plans and operations of Presidio; costs related to the potential Business Combination; changes in laws and regulations; risks related to the domestication of EQV as a Delaware corporation; risks related to Pubco’s ability to pay expected dividends; the extent of participation in rollover agreements; the amount of redemption requests made by EQV’s public equity holders; and the ability of EQV or Pubco to issue equity or equity-linked securities or issue debt securities or enter into debt financing arrangements in connection with the proposed Business Combination or in the future. Additional information concerning these and other factors that may impact such forward-looking statements can be found in filings and potential filings by Presidio, EQV, EQVR or Pubco resulting from the proposed Business Combination with the SEC, including under the heading “Risk Factors” in the Registration Statement. If any of these risks materialize or any assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that none of Pubco, Presidio, EQVR nor EQV presently know or that Pubco, Presidio, EQVR or EQV currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by investors as a guarantee, an assurance, a prediction or a definitive statement of fact or probability.

In addition, forward-looking statements reflect Pubco’s, Presidio’s, EQVR’s and EQV’s expectations, plans or forecasts of future events and views as of the date they are made. Pubco, Presidio, EQVR  and EQV anticipate that subsequent events and developments will cause Pubco’s, Presidio’s, EQVR’s and EQV’s assessments to change. However, while Pubco, Presidio, EQVR and EQV may elect to update these forward-looking statements at some point in the future, Pubco, Presidio, EQVR and EQV specifically disclaim any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Pubco’s, Presidio’s, EQVR’s or EQV’s assessments as of any date subsequent to the date they are made. Accordingly, undue reliance should not be placed upon the forward-looking statements. None of Pubco, Presidio, EQVR or EQV, or any of their respective affiliates have any obligation to update these forward-looking statements other than as required by law.

Additional Information and Where to Find It

In connection with the proposed Business Combination, Pubco, EQVR and Presidio filed the Registration Statement with the SEC, which includes a prospectus with respect to Pubco’s securities to be issued in connection with the proposed Business Combination and a proxy statement with respect to the shareholder meeting of EQV to vote on the proposed Business Combination. EQV, Pubco, EQVR and Presidio also plan to file other documents and relevant materials with the SEC regarding the proposed Business Combination. The Registration Statement was declared effective by the SEC on January 30, 2026. Mailing of the definitive Proxy Statement/Prospectus to EQV’s shareholders of record as of January 30, 2026 commenced on January 30, 2026. The Proxy Statement/Prospectus includes information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to EQV’s shareholders in connection with the proposed Business Combination. SECURITY HOLDERS OF EQV AND OTHER INTERESTED PARTIES ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND OTHER DOCUMENTS AND RELEVANT MATERIALS RELATING TO THE PROPOSED BUSINESS COMBINATION THAT HAVE BEEN AND WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BEFORE MAKING ANY VOTING DECISION WITH RESPECT TO THE PROPOSED BUSINESS COMBINATION BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED BUSINESS COMBINATION AND THE PARTIES TO THE PROPOSED BUSINESS COMBINATION. Shareholders are able to obtain free copies of the Proxy Statement/Prospectus and other documents containing important information about Pubco, Presidio, EQVR and EQV once such documents are filed with the SEC through the website maintained by the SEC at http://www.sec.gov. In addition, the documents filed by EQV may be obtained free of charge from EQV at www.eqvventures.com. Alternatively, these documents, when available, can be obtained free of charge from EQV or Pubco upon written request to EQV Ventures Acquisition Corp., 1090 Center Drive, Park City, Utah, 84098, Attn: Secretary, or by calling (405) 870-3781. The information contained on, or that may be accessed through the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release.

Participants in the Solicitation

EQV, Presidio, EQVR, Pubco and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of EQV in connection with EQV’s shareholder meeting. Security holders may obtain more detailed information regarding the names, affiliations and interests of certain of EQV’s executive officers and directors in the solicitation by reading EQV’s annual report on Form 10-K, filed with the SEC on March 31, 2025, the definitive Proxy Statement/Prospectus, filed with the SEC on January 30, 2026, the Registration Statement and other relevant materials filed with the SEC in connection with the proposed Business Combination when they become available. Information concerning the interests of EQV’s participants in the solicitation, which may, in some cases, be different from those of EQV’s shareholders generally, is set forth in the definitive Proxy Statement/Prospectus and the Registration Statement.

No Offer or Solicitation

This press release shall not constitute a solicitation of any proxy, vote, consent or approval in any jurisdiction in connection with the proposed Business Combination and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of EQV, PIH, EQVR or Pubco, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended. This press release is restricted by law; it is not intended for distribution to, or use by any person in, any jurisdiction in where such distribution or use would be contrary to local law or regulation.

Pubco Media and Investor Contact:

[email protected]

For EQV:

[email protected] 

Source: EQV Ventures Acquisition Corp.

January 30, 2026 17:15 ET  | Source: Enzon Pharmaceuticals, Inc

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today announced that it has commenced an exchange offer (the “Offer”) involving its Series C Non-Convertible Redeemable Preferred Stock (the “Series C Preferred Stock”) identified in the Prospectus/Consent Solicitation/Offer to Exchange (as defined below) in connection with Enzon’s previously announced merger with Viskase Companies, Inc. (“Viskase”).

What’s Being Offered

Enzon is offering all holders of outstanding shares of Series C Preferred Stock the chance to exchange their shares for shares of Enzon’s common stock, par value $0.01 per share (the “Common Stock”). Each share of Series C Preferred Stock can be exchanged for an amount of Common Stock equal to (i) the aggregate liquidation preference of each share of Series C Preferred Stock, divided by (ii) $7.83 after giving effect to the Reverse Stock Split (as defined in the Prospectus/Consent Solicitation/Offer to Exchange, dated January 28, 2026 (the “Prospectus/Consent Solicitation/Offer to Exchange”)).

Key Dates and Information

Deadline to Participate: The offer expires at one minute after 11:59 p.m., Eastern Time, on Friday, February 27, 2026, unless extended.Holders of Series C Preferred Stock who elect to participate in the Offer can withdraw their tendered shares any time before the deadline. Offer Details

The Offer is described in full in the Prospectus/Consent Solicitation/Offer to Exchange, filed with the U.S. Securities and Exchange Commission on January 28, 2026, and the Schedule TO (as defined below), filed with the U.S. Securities and Exchange Commission on January 30, 2026.

Common Stock Symbol: ENZN (quoted on the “OTCQB” tier of the OTC market)Preferred Stock: Not publicly traded; 40,000 shares outstanding as of January 30, 2026 HKL & Co., LLC has been appointed as the Information Agent for the Offer, and Continental Stock Transfer & Trust Company has been appointed as the Exchange Agent. Requests for documents should be directed to HKL & Co., LLC at +1 (800) 326-5997 (for individuals) or +1 (212) 468-5380 (for banks and brokers) or via the following email address: [email protected].

About Enzon Pharmaceuticals, Inc.

Enzon Pharmaceuticals, Inc., together with its subsidiary, is positioned as a public company acquisition vehicle, that has sought to become an acquisition platform.

Important Additional Information Has Been Filed with the SEC

The Offer commenced on January 30, 2026. On January 28, 2026, a registration statement on Form S-4 and preliminary prospectus included therein and an exchange offer statement on Schedule TO (the “Schedule TO”), including an offer to exchange, a letter of transmittal and consent and related documents, were filed with the SEC by the Company. The offer to exchange the outstanding shares of Series C Preferred Stock of the Company will only be made pursuant to the Prospectus/Consent Solicitation/Offer to Exchange and Schedule TO, including related documents filed as a part of the Offer. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROSPECTUS/CONSENT SOLICITATION/OFFER TO EXCHANGE AND SCHEDULE TO FILED OR TO BE FILED WITH THE SEC CAREFULLY, AS THEY MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION THAT INVESTORS AND SECURITY HOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING THE EXCHANGE OFFER, INCLUDING THE TERMS AND CONDITIONS OF THE EXCHANGE OFFER. Investors and security holders may obtain a free copy of these statements (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to HKL & Co., LLC at +1 (800) 326-5997 (for individuals) or +1 (212) 468-5380 (for banks and brokers) or via the following email address: [email protected]. Investors and security holders may also obtain, at no charge, the documents filed or furnished to the SEC by the Company under the “Investors” section of the Company’s website at https://investor.enzon.com/.

No Offer or Solicitation

This press release shall not constitute an offer to exchange or the solicitation of an offer to exchange or the solicitation of an offer to purchase any securities, nor shall there be any exchange or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The Offer is being made only through the Schedule TO and Prospectus/Consent Solicitation/Offer to Exchange, and the complete terms and conditions of the Offer are set forth in the Schedule TO and Prospectus/Consent Solicitation/Offer to Exchange.

None of the Company, any of its management or its board of directors, or the Information Agent or the Exchange Agent makes any recommendation as to whether or not holders of shares of Series C Preferred Stock should tender shares of Series Preferred Stock for exchange in the Offer.

Forward-Looking Statements

Certain statements contained in this filing may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding the proposed transaction involving Enzon and Viskase, the ability to consummate the proposed transaction, the ability to consummate the Offer, the timing of the Expiration Date, and the ability to quote the common stock of the combined company on the “OTCQB” tier of the OTC market of the OTC Markets Group, Inc. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the proposed transaction are not satisfied, including the failure to obtain the necessary approvals for the proposed transaction; (ii) uncertainties as to the timing of the consummation of the proposed transaction, including timing for satisfaction of the closing conditions, and the ability of each of Enzon and Viskase to consummate the proposed transaction; (iii) the ability of Viskase to timely deliver the financial statements required by the Merger Agreement, as amended; (iv) the possibility that other anticipated benefits of the proposed transaction will not be realized, including without limitation, anticipated revenues, expenses, earnings and other financial results, and growth and expansion of the combined company’s operations, and the anticipated tax treatment of the combination; (v) potential litigation relating to the proposed transaction that could be instituted against Enzon, Viskase or their respective officers or directors; (vi) possible disruptions from the proposed transaction that could harm Enzon’s or Viskase’s respective businesses; (vii) the ability of Viskase to retain, attract and hire key personnel; (viii) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the proposed transaction; (ix) potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Enzon’s or Viskase’s financial performance; (x) certain restrictions during the pendency of the proposed transaction that may impact Enzon’s or Viskase’s ability to pursue certain business opportunities or strategic transactions; (xi) the exchange ratio and relative ownership levels as of the closing of the transactions contemplated by the Merger Agreement, as amended; (xii) estimates regarding future revenue, expenses, and capital requirements following the closing of the transactions contemplated by the Merger Agreement, as amended; (xiii) legislative, regulatory and economic developments; (xiv) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, trade wars, or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors; and (xv) such other risks and uncertainties, including those that are set forth in the Registration Statement under the heading “Risk Factors”, in Enzon’s periodic public filings with the SEC, and in Viskase’s annual and quarterly reports posted to Viskase’s website. Enzon and Viskase can give no assurance that the conditions to the proposed transaction will be satisfied. Except as required by applicable law, neither Enzon, nor Viskase undertakes any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

For Media Inquiries:
Richard L. Feinstein, CEO and CFO
Email: [email protected]

Brookdale Senior Living Inc. (BKD) Analyst/Investor Day Transcript

As I anticipated in my Q4 earnings preview, the story around Tesla, Inc.'s physical AI platform outweighed the fundamentals during the quarter. Q4 results showed auto revenue down 11% YOY, FCF down 30% YOY, and both GAAP and non-GAAP EPS down sharply YOY. That said, the Street consensus was overly pessimistic. Management is now accelerating autonomy and robotics, discontinuing Model S/X for Optimus production, and targeting 1M humanoid robots annually (long term).

, /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that, on January 21, 2026, the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase 1,600 shares of its common stock to one newly-hired employee under Nektar's 2025 Inducement Plan.

Nektar's 2025 Inducement Plan was adopted by its Board of Directors on November 6, 2025 and is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Nektar (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with Nektar, pursuant to Nasdaq Listing Rule 5635(c)(4).

The stock options have an exercise price per share equal to $36.92, which is equal to the closing price of Nektar's common stock on January 21, 2026. The stock options have an eight-year term and will vest over four years with 1/4th of the shares vesting on the one-year anniversary of the employee's grant date and 1/48th of the shares vesting monthly thereafter over the next three years, subject to each employee's continued employment with Nektar on such vesting dates. The stock options are subject to the terms and conditions of Nektar's 2025 Inducement Plan, and the terms and conditions of the stock option agreement covering the grant.

About Nektar Therapeutics

Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. Nektar's lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell stimulator being evaluated in two Phase 2b clinical trials, one in atopic dermatitis, one in alopecia areata, and in one Phase 2 clinical trial in Type 1 diabetes mellitus. Nektar's pipeline also includes a preclinical bivalent tumor necrosis factor receptor type II (TNFR2) antibody and bispecific programs, NKTR-0165 and NKTR-0166, and a modified hematopoietic colony stimulating factor (CSF) protein, NKTR-422. Nektar, together with various partners, is also evaluating NKTR-255, an investigational IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer, in several ongoing clinical trials.

Nektar is headquartered in San Francisco, California. For further information, visit www.nektar.com and follow us on LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements which can be identified by words such as: "could," "develop," "evaluate," "address," "may" and similar references to future periods. Examples of forward-looking statements include, among others, statements regarding the therapeutic potential of, and future development plans for, rezpegaldesleukin, NKTR-0165, NKTR-0166, NKTR-422, and NKTR-255. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include, among others: (i) our statements regarding the therapeutic potential of rezpegaldesleukin, NKTR-0165, NKTR-0166, NKTR-422 and NKTR-255 are based on preclinical and clinical findings and observations and are subject to change as research and development continue; (ii) rezpegaldesleukin, NKTR-0165, NKTR-0166, NKTR-422 and NKTR-255 are investigational agents and continued research and development for these drug candidates is subject to substantial risks, including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166, NKTR-422 and NKTR-255 are in clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval; (iv) data reported from ongoing clinical trials are necessarily interim data only and the final results will change based on continuing observations; (v) the timing of the commencement or end of clinical trials and the availability of clinical data may be delayed or unsuccessful due to regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, evolving regulatory requirements, clinical trial design, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (vi) a Fast Track designation does not increase the likelihood that rezpegaldesleukin will receive marketing approval in the United States; (vii) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (viii) certain other important risks and uncertainties set forth in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contacts:

For Investors:

Vivian Wu
[email protected]

Corey Davis, Ph.D.
LifeSci Advisors, LLC
[email protected]
212-915-2577

Ahu Demir, Ph.D.
LifeSci Advisors, LLC
[email protected]
212-915-3820

For Media:

Jonathan Pappas
LifeSci Communications
857-205-4403
[email protected]

SOURCE Nektar Therapeutics

Warehouses De Pauw SA (WDPSF) Q4 2025 Earnings Call Transcript

CaixaBank, S.A. (CAIXY) Q4 2025 Earnings Call January 30, 2026 3:00 AM EST

Company Participants

Marta Noguer - Head of Investor and Shareholder Relations
Gonzalo Gortázar Rotaeche - CEO & Executive Director
Matthias Bulach - Head of Accounting, Mgmt Control & Capital

Conference Call Participants

Antonio Reale - BofA Securities, Research Division
Ignacio Ulargui - BNP Paribas, Research Division
Maksym Mishyn - JB Capital Markets, Sociedad de Valores, S.A., Research Division
Francisco Riquel - Alantra Equities Sociedad de Valores, S.A., Research Division
Cecilia Romero Reyes - Barclays Bank PLC, Research Division
Sofie Caroline Peterzens - Goldman Sachs Group, Inc., Research Division
Alvaro de Tejada - Morgan Stanley, Research Division
Marta Sánchez Romero - JPMorgan Chase & Co, Research Division
Ignacio Cerezo Olmos - UBS Investment Bank, Research Division
Andrea Filtri - Mediobanca - Banca di credito finanziario S.p.A., Research Division
Borja Ramirez Segura - Citigroup Inc., Research Division
Miruna Chirea - Jefferies LLC, Research Division
Lento Tang

Presentation

Marta Noguer
Head of Investor and Shareholder Relations

Good morning, and welcome to CaixaBank results presentation for the fourth quarter and the full year 2025. We are joined today by our CEO, Gonzalo Gortazar; and by Matthias Bulach, our Chief Accounting Management Control and Capital Officer, who also sits at the Management Committee. Our CFO, Javier Pano, is temporarily away on sick leave, but he's recovering well and expected to return shortly.

In terms of logistics, same as usual, we plan to spend about 30 minutes with the presentation and about 45 minutes to 1 hour with the Q&A. The Q&A is live, and you should have received instructions by e-mail on how to participate. Needless to say, my team and I will be at your full disposal after the call. And without further ado, Gonzalo, the floor is yours.

Gonzalo Gortázar Rotaeche
CEO & Executive Director

Thank you, Marta, and good morning, everybody. Thanks for taking the time. And

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2026) - Dryden Gold Corp. (TSXV: DRY) (OTCQB: DRYGF) (FSE: X7W) ("Dryden Gold" or the "Company is pleased to announce that it has closed (the "Closing") its previously announced (January 8, 2026, January 9, 2026) upsized non-brokered equity financing (the "Upsized Offering"). The Upsized Offering was comprised of 4,350,000 charity flow-through common shares (the "CFT Shares") at a price of $0.425 per CFT Share for aggregate gross proceeds of $1,848,750.

The CFT Shares will qualify as "flow-through shares", as defined in subsection 66(15) of the Income Tax Act (Canada) (the "Tax Act") and "Ontario focused flow-through shares", as defined in subsection 103(7) of the Taxation Act, 2007 (Ontario) ("Ontario Tax Act"). No finders' fees were paid in connection with the Upsized Offering.

An amount equal to the gross proceeds from the issuance of the CFT Shares will be used to incur eligible resource exploration expenses which will qualify as (i) "Canadian exploration expenses", as defined in subsection 66.1(6) of the Tax Act, (ii) provided Bill C-15, Budget 2025 Implementation Act, No. 1 receives Royal Assent, as "flow-through mining expenditures" as defined in subsection 127(9) of the Tax Act, and (iii) for certain Ontario purchasers, as "eligible Ontario exploration expenditures", as defined in subsection 103(4) of the Ontario Tax Act ("Qualifying Expenditures"). All Qualifying Expenditures will be renounced in favor of the subscribers for the CFT Shares effective on or before December 31, 2026.

The issuance of the shares under the offering remains subject to the final acceptance by the TSX Venture Exchange (the "TSXV") and compliance with applicable regulatory requirements including requirements under National Instrument 45-106 - Prospectus Exemptions ("NI 45-106").

ABOUT DRYDEN GOLD CORP.

Dryden Gold Corp. is an exploration company focused on the discovery of high-grade gold mineralization listed on the TSX Venture Exchange ("DRY"), on the OTCQB marketplace ("DRYGF") and on the FSE: ("X7W "). The Company has a strong management team and Board of Directors comprised of experienced individuals with a track record of building shareholder value through property acquisition and consolidation, exploration success, and mergers and acquisitions. Dryden Gold controls a 100% interest in a dominant strategic land position in the Dryden District of Northwestern Ontario. Dryden Gold's property package includes historic gold mines but has seen limited modern exploration. The property hosts high-grade gold mineralization over 50km of potential strike length along the Manitou-Dinorwic deformation zone. The property has excellent infrastructure, enjoys collaborative relationships with First Nations communities and benefits from proximity to an experienced mining workforce.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements
The information contained herein contains "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: receipt of corporate and regulatory approvals, issuance of common shares; future development plans; and the business and operations of Dryden Gold. Forward-looking statements relate to information that is based on assumptions of management, forecasts of future results, and estimates of amounts not yet determinable. Any statements that express predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be "forward-looking statements." Forward-looking statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation: risks related to failure to obtain adequate financing on a timely basis and on acceptable terms; political and regulatory risks associated with mining and exploration; risks related to the maintenance of stock exchange listings including receipt of TSX Venture Exchange approval for the offering; risks related to environmental regulation and liability; the potential for delays in exploration or development activities; the uncertainty of profitability; risks and uncertainties relating to the interpretation of drill results, the geology, grade and continuity of mineral deposits; risks related to the inherent uncertainty of production and cost estimates and the potential for unexpected costs and expenses; the possibility that future exploration, development or mining results will not be consistent with the Company's expectations; risks related to commodity price fluctuations; and other risks and uncertainties related to the Company's prospects, properties and business detailed elsewhere in Dryden Gold's and the Company's disclosure record. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements. Investors are cautioned against attributing undue certainty to forward--looking statements. These forward-looking statements are made as of the date hereof and Dryden Gold and the Company do not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from Dryden Gold's and the Company's expectations or projections.

UNITED STATES ADVISORY. The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), have been offered and sold outside the United States to eligible investors pursuant to Regulation S promulgated under the U.S. Securities Act, and may not be offered, sold, or resold in the United States or to, or for the account of or benefit of, a U.S. Person (as such term is defined in Regulation S under the United States Securities Act) unless the securities are registered under the U.S. Securities Act, or an exemption from the registration requirements of the U.S. Securities Act is available. Hedging transactions involving the securities must not be conducted unless in accordance with the U.S. Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in the state in the United States in which such offer, solicitation or sale would be unlawful.

NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATION INTO THE USA

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282245

Source: Dryden Gold Corp.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

ELMER, N.J.--(BUSINESS WIRE)--ELMER BANCORP, INC. (“Elmer Bancorp” or the “Company”) (OTCID: ELMA), the parent company of The First National Bank of Elmer (the “Bank”), announces its operating results for the fourth quarter and full year ended December 31, 2025.

For the three months ended December 31, 2025, Elmer Bancorp reported net income of $718,000, or $0.63 per common share compared to $715,000, or $0.63 per common share for the quarter ended December 31, 2024. For the twelve months ended December 31, 2025, net income totaled $3.302 million, or $2.89 per common share compared to $2.851 million, or $2.50 per common share for the twelve months ended December 31, 2024.

Net interest income for the three months ended December 31, 2025 totaled $4.036 million, an increase of $337,000 from the three months ended December 31, 2024 total of $3.699 million. This increase in net interest income is the result of higher interest and fees on loans and higher income on our overnight investments partially offset by higher interest paid on deposits. For the twelve months ended December 31, 2025, net interest income totaled $15.928 million, an increase of $1.343 million from the twelve months ended December 31, 2024 total of $14.585 million. This increase in net interest income for the twelve-month period results from higher interest and fees on loans resulting from core loan growth year-over-year partially offset by lower interest income on our overnight investments and higher interest paid on deposits. The loan loss provision was increased by $33,000 in the fourth quarter of 2025 and increased by $156,000 for the twelve months ended December 31, 2025 compared to an increase of $20,000 in the fourth quarter of 2024 and a decrease of $47,000 for the twelve months ended December 31, 2024. The variances in the loan loss provision are the result of the required loan loss calculation under the Current Expected Credit Loss (“CECL”) model. The allowance for loan losses was 1.27% of total core loans at December 31, 2025 compared to 1.28% of total core loans at December 31, 2024.

Non-interest income for the three months ended December 31, 2025 was $30,000 higher than the same three-month period a year ago and $627,000 higher than the twelve-month period last year. Increases in the cash surrender value of Bank Owned Life Insurance (“BOLI”) and increases in service fee income accounted for the increase in the three-month period. For the increase in the twelve-month period, the one-time BOLI payout of $530,000, higher service fee income and increased Visa credit card commissions were partially offset by no loss on Other Real Estate Owned (“OREO”).

Non-interest expenses for the three months ended December 31, 2025 were $355,000 higher than the same three-month period a year ago and $1.361 million higher than the twelve-month period last year. For the three-month period, the increase was the result of increases in employment costs, professional fees and other operating costs partially offset by a decrease in OREO expenses. For the twelve-month period, the increase was the result of higher employment costs, professional fees and occupancy and equipment expenses partially offset by lower OREO expenses.

Elmer Bancorp’s total assets at December 31, 2025 totaled $409.4 million, an increase of $28.7 million from the December 31, 2024 level of $380.7 million. Excluding $6.5 million in overnight funds from a large temporary deposit in December 2025, total core assets increased $22.2 million. Total loans were $327.3 million at December 31, 2025, an increase of $12.9 million from the December 31, 2024 total of $314.4 million. In addition, overnight investments increased $16.2 million.

Deposits totaled $367.9 million at December 31, 2025, an increase of $24.4 million from the December 31, 2024 level of $343.5 million. Excluding the December 31, 2025 large temporary deposit of $6.5 million, total core deposits increased $17.9 million. The positive variance from December 31, 2024 resulted from increases in certificates of deposit ($13.3 million), money market accounts ($7.3 million), demand deposits ($4.2 million) and interest-bearing checking accounts ($2.3 million) partially offset by decreases in savings deposits ($2.3 million) and IRA accounts ($847,000). This increase in deposits is the result of a money market and CD promotion to obtain new deposits. The Bank will continue to evaluate the current deposit environment and adjust, as appropriate, to maintain its strong deposit base. Stockholders’ equity totaled $39.1 million at December 31, 2025 compared to $35.4 million at December 31, 2024, an increase of $3.7 million. Elmer Bancorp’s book value per common share at December 31, 2025 was $33.91 per share compared to $30.91 per share at December 31, 2024. The Company and the Bank met all regulatory capital requirements at December 31, 2025.

Brian W. Jones, President and Chief Executive Officer, commented, “We are very pleased to report record net income of $3.302 million for year-end 2025 driven primarily by strong loan and deposit growth. Our total assets crossed the $400 million threshold reaching $409.4 million in the fourth quarter of 2025. Total loans increased $12.9 million to $327.3 million or 4.1%. Core deposit growth was $17.9 million or an increase of 5.2%. Our Loan Production Office (“LPO”) in Marlton continues to produce excellent results and support our client base in Burlington and Camden Counties. It was also a year of advancement in our service and product offerings, such as Positive Pay for business accounts, our new True Grow account and a new Instagram presence. As we look forward to 2026, I would like to thank our loyal customer base, our outstanding team members and our Board of Directors for their ongoing support.”

Chairman, P. Scott Boyer, stated, “I want to thank all of our employees for their dedication and hard work that resulted in 2025 being the best year in our Bank's history.”

The First National Bank of Elmer, a nationally chartered bank headquartered in Elmer, New Jersey, has a long history of serving the community since its beginnings in 1903. We are a community bank focused on providing deposit and loan products to retail customers and to small and mid-sized businesses from our six full-service branch offices located in Cumberland, Gloucester and Salem Counties, New Jersey, including our main office located at 10 South Main Street in Elmer, New Jersey. In addition to our branch offices, the bank also operates a loan production office (“LPO”) located in Marlton, NJ to service our clients in Burlington County. Deposits at The First National Bank of Elmer are insured up to the legally maximum amount by the Federal Deposit Insurance Corporation (FDIC).

For more information about Elmer Bank and its products and services, please visit our website at www.ElmerBank.com or call toll free 1-877-358-8141.

Forward-Looking Statements

This press release and other statements made from time to time by the Company’s management contain express and implied statements relating to our future financial condition, results of operations, credit quality, corporate objectives, and other financial and business matters, which are considered forward-looking statements. These forward-looking statements are necessarily speculative and speak only as of the date made, and are subject to numerous assumptions, risks and uncertainties, all of which may change over time. Actual results could differ materially from those expected or implied by such forward-looking statements. Risks and uncertainties which could cause our actual results to differ materially and adversely from such forward-looking statements include economic conditions affecting the financial industry: changes in interest rates and shape of the yield curve, credit risk associated with our lending activities, risks relating to our market area, significant real estate collateral and the real estate market, operating, legal and regulatory risk, fiscal and monetary policy, economic, political and competitive forces affecting our business, our ability to identify and address cyber-security risks, and management’s analysis of these risks and factors being incorrect, and/or the strategies developed to address them being unsuccessful. Any statements made that are not historical facts should be considered forward-looking statements. You should not place undue reliance on any forward-looking statements. We undertake no obligation to update forward-looking statements or to make any public announcement when we consider forward-looking statements to no longer be accurate, whether as a result of new information of future events, except as may be required by applicable law or regulation.

ELMER BANCORP, INC. AND SUBSIDIARIES SELECTED FINANCIAL DATA (unaudited)   Twelve Months Ended

Three Months Ended

12/31/2025

12/31/2024

12/31/2025

9/30/2025

6/30/2025

3/31/2025

Statement of Income Data: (dollars in thousands, except per share data)   Interest income $

20,429

$

18,270

$

5,231

$

5,293

$

5,151

$

4,754

Interest expense 4,501

3,685

1,195

1,182

1,150

973

Net interest income 15,928

14,585

4,036

4,111

4,001

3,781

Provision for loan losses 156

(47

)

33

40

44

40

Net interest income after provision for loan losses 15,772

14,632

4,003

4,071

3,957

3,741

Non-interest income 1,720

1,093

316

298

287

818

Non-interest expense 13,232

11,871

3,355

3,334

3,249

3,293

Income before income tax expense 4,260

3,854

964

1,035

995

1,266

Income tax expense 958

1,003

246

267

258

187

Net income $

3,302

$

2,851

$

718

$

768

$

737

$

1,079

  Earnings per share: Basic $

2.89

$

2.50

$

0.63

$

0.67

$

0.64

$

0.94

Diluted $

2.89

$

2.50

$

0.63

$

0.67

$

0.64

$

0.94

Weighted average basic shares outstanding 1,143,927

1,141,063

1,145,841

1,144,985

1,144,142

1,144,914

Weighted average diluted shares outstanding 1,144,200

1,141,661

1,146,570

1,145,490

1,144,423

1,146,095

Book value per share $

33.91

$

30.91

$

33.91

$

33.36

$

32.44

$

31.86

  Statement of Condition Data (Period End): 12/31/2025

12/31/2024

12/31/2025

9/30/2025

6/30/2025

3/31/2025

  Cash & due from banks $

46,422

$

30,246

$

46,422

$

51,203

$

47,293

$

29,774

Total investments 23,223

23,053

23,223

23,246

23,150

23,173

Total gross loans 327,269

314,365

327,269

323,248

322,262

320,385

Allowance for loan losses (4,162

)

(4,035

)

(4,162

)

(4,122

)

(4,077

)

(4,030

)

Accrued interest receivable 1,019

949

1,019

1,006

958

937

Premises & equipment, net 3,722

3,764

3,722

3,764

3,796

3,821

Other real estate owned -

1,134

-

-

-

-

Bank owned life insurance 8,848

8,101

8,848

8,774

7,703

7,641

Other assets 3,078

3,148

3,078

3,039

3,496

3,217

Total assets $

409,419

$

380,725

$

409,419

$

410,158

$

404,581

$

384,918

  Total deposits $

367,905

$

343,459

$

367,905

$

369,217

$

365,275

$

346,048

Accrued interest payable 252

190

252

235

178

149

Other liabilities 2,212

1,693

2,212

2,278

1,756

2,021

Total liabilities $

370,369

$

345,342

$

370,369

$

371,730

$

367,209

$

348,218

Total stockholders' equity $

39,050

$

35,383

$

39,050

$

38,428

$

37,372

$

36,700

Total liabilities & stockholders' equity $

409,419

$

380,725

$

409,419

$

410,158

$

404,581

$

384,918

More News From Elmer Bancorp, Inc.

WEST PALM BEACH, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Onity Group Inc. (NYSE: ONIT) (“Onity”) today announced that its subsidiaries, PHH Corporation and PHH Escrow Issuer LLC (the “Issuers”), closed their previously announced offering of 9.875% Senior Notes due 2029 (the “PHH Senior Notes”) in an aggregate principal amount of $200 million.

Glen A. Messina, Chair, President and CEO of Onity Group, said, “We opportunistically executed this debt offering to expand and strengthen our capital structure at attractive terms. We are pleased with the strong investor demand for this offering which reflects the continued confidence in our strategy and financial results. With an effective yield on this debt issuance of nearly 148 basis points lower than the original debt issuance in November 2024, we believe this transaction will provide greater financial flexibility to manage our leverage and invest in the growth of our business.”

The PHH Senior Notes were offered as an additional issuance of the Issuers’ 9.875% Senior Notes due 2029 and formed a single series of debt securities with the $500.0 million aggregate principal amount of such notes that were originally issued on November 6, 2024. The PHH Senior Notes were guaranteed on a senior secured basis by Onity and certain of PHH’s subsidiaries, including PHH Mortgage Corporation (“PMC”) and PHH Asset Services LLC (“PAS”).

The net proceeds from the offering will be used for general corporate purposes, including the repayment of mortgage servicing rights (MSR) indebtedness.

The PHH Senior Notes and the related guarantees were not and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any other jurisdiction.

The PHH Senior Notes were sold only to persons reasonably believed to be qualified institutional buyers in reliance on the exemption from registration provided by Rule 144A of the Securities Act and to non-U.S. persons outside of the United States in compliance with Regulation S of the Securities Act.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any offer or sale of, any security in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Onity Group

Onity Group Inc. (NYSE: ONIT) is a leading non-bank financial services company providing mortgage servicing and originations solutions through its primary brands, PHH Mortgage and Liberty Reverse Mortgage. PHH Mortgage is one of the largest servicers in the country, focused on delivering a variety of servicing and lending programs to consumers and business clients. Liberty is one of the nation’s largest reverse mortgage lenders dedicated to providing loans that help customers meet their personal and financial needs. We are headquartered in West Palm Beach, Florida, with offices and operations in the United States, the U.S. Virgin Islands, India and the Philippines, and have been serving our customers since 1988.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by a reference to a future period or by the use of forward-looking terminology such as “will be” and references to goals, strategies, and agendas, although not all forward-looking statements contain these words. Forward-looking statements in this press release include statements relating to the debt issuance providing greater financial flexibility to manage leverage and invest in the growth of Onity’s business.

Forward-looking statements involve a number of assumptions, risks and uncertainties that could cause actual results to differ materially. Important factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, but are not limited to, the timing for receipt of required consents to close our previously announced transaction with Finance of America Reverse LLC, the timing for receipt of required consents to transfer certain Rithm Capital Corp. (Rithm) assets, the size of the portfolio at the time of the Rithm transfer, Onity’s ability to restructure its operations in a timely and cost-effective manner in response to Rithm servicing transfers, Onity’s ability to identify and execute on alternative sources of revenue for its servicing business, Onity’s ability to adjust its liquidity management practices due to the reduction of servicing float balances associated with the Rithm agreements, the potential for ongoing disruption in the financial markets and in commercial activity generally as a result of U.S. and global political events, changes in monetary and fiscal policy, and other sources of instability; the impacts of inflation, employment disruption, and other financial difficulties facing our borrowers; the timing and amount of a release of the valuation allowance offsetting our net U.S. deferred tax asset; the adequacy of our financial resources, including our sources of liquidity and ability to sell, fund and recover servicing advances, forward and reverse whole loans, future draws on existing reverse loans, and HECM and forward loan buyouts and put backs, as well as repay, renew and extend borrowings, borrow additional amounts as and when required, meet our MSR or other asset investment objectives and comply with our debt agreements, including the financial and other covenants contained in them; our ability to interpret correctly and comply with current or future liquidity, net worth and other financial and other requirements of regulators, the Federal National Mortgage Association (Fannie Mae), and Federal Home Loan Mortgage Corporation (Freddie Mac) (together, the GSEs), and the Government National Mortgage Association (Ginnie Mae); the impact of cost-reduction initiatives on our business and operations; the impact of our rebranding initiative; the amount of senior debt or common stock that we may repurchase under any repurchase programs, the timing of such repurchases, and the long-term impact, if any, of repurchases on the trading price of our securities or our financial condition; breach or failure of Onity’s, our contractual counterparties’, or our vendors’ information technology or other security systems or privacy protections, including any failure to protect customers’ data, resulting in disruption to our operations, loss of income, reputational damage, costly litigation and regulatory penalties; our reliance on our technology vendors to adequately maintain and support our systems, including our servicing systems, loan originations and financial reporting systems, and uncertainty relating to our ability to transition to alternative vendors, if necessary, without incurring significant cost or disruption to our operations; the extent to which MSR Asset Vehicle LLC (MAV) will exercise its rights to sell MSRs subserviced by PHH and the impact to our subservicing portfolio; our ability to close acquisitions of MSRs and other transactions, including the ability to obtain regulatory approvals; our ability to grow our reverse servicing business; our ability to retain clients and employees of acquired businesses, and the extent to which acquisitions and our other strategic initiatives will contribute to achieving our growth objectives; increased servicing costs based on increased borrower delinquency levels or other factors; uncertainty related to past, present or future claims, litigation, cease and desist orders and investigations regarding our servicing, foreclosure, modification, origination and other practices brought by government agencies and private parties, including state regulators, the Consumer Financial Protection Bureau (CFPB), State Attorneys General, the Securities and Exchange Commission (SEC), the Department of Justice or the Department of Housing and Urban Development (HUD); the reactions of key counterparties, including lenders, the GSEs and Ginnie Mae, to our regulatory engagements and litigation matters; increased regulatory scrutiny and media attention; any adverse developments in existing legal proceedings or the initiation of new legal proceedings; our ability to effectively manage our regulatory and contractual compliance obligations; our ability to comply with our servicing agreements, including our ability to comply with the requirements of the GSEs and Ginnie Mae and maintain our seller/servicer and other statuses with them; our ability to fund future draws on existing loans in our reverse mortgage portfolio; our servicer and credit ratings as well as other actions from various rating agencies, including any future downgrades; as well as other risks and uncertainties detailed in our reports and filings with the SEC, including our annual report on Form 10-K for the year ended December 31, 2024 and any current report or quarterly report filed with the SEC since such date. Onity’s forward-looking statements speak only as of the date they are made and Onity disclaims any obligation to update or revise forward-looking statements whether as a result of new information, future events or otherwise.

For Further Information Contact:

Investors:

Valerie Haertel, VP, Investor Relations
(561) 570-2969
[email protected]

Media:

Dico Akseraylian, SVP, Corporate Communications
(856) 917-0066
[email protected]

January 30, 2026 16:15 ET  | Source: Arbor Realty Trust

UNIONDALE, N.Y., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced the tax treatment of its 2025 dividend distributions for common and preferred shares of beneficial interest.

For tax reporting purposes, 100% of the distributions paid on our common stock during 2025 will be classified as dividend income. The 2025 taxable distributions with respect to our common stock traded under ticker symbol ABR are summarized as follows:

           Common Shares (CUSIP #038923108)Record Date Payment Date Total Distribution Per Share Non-Qualified Dividend (1) Qualified Dividend Capital Gain Distribution3/7/2025 3/21/2025 $0.43 $0.19 $0.24 $0.005/16/2025 5/30/2025 0.30 0.13 0.17 0.008/15/2025 8/29/2025 0.30 0.13 0.17 0.0011/14/2025 11/26/2025 0.30 0.13 0.17 0.00    $1.33 $0.58 $0.75 $0.00            The 2025 taxable distributions with respect to our 6.375% Series D Cumulative Redeemable Preferred Stock traded under ticker symbol ABR-PD are summarized as follows:

           6.375% Series D Cumulative Redeemable Preferred Stock (CUSIP #038923876)Record Date Payment Date Total Distribution Per Share Non-Qualified Dividend (1) Qualified Dividend Capital Gain Distribution1/15/2025 1/30/2025 $0.398438 $0.178369 $0.220069 $0.004/15/2025 4/30/2025 0.398438 0.178369 0.220069 0.007/15/2025 7/30/2025 0.398438 0.178369 0.220069 0.0010/15/2025 10/30/2025 0.398438 0.178369 0.220069 0.00    $1.593750 $0.713475 $0.880275 $0.00            The 2025 taxable distributions with respect to our 6.25% Series E Cumulative Redeemable Preferred Stock traded under ticker symbol ABR-PE are summarized as follows:

           6.25% Series E Cumulative Redeemable Preferred Stock (CUSIP #038923868)Record Date Payment Date Total Distribution Per Share Non-Qualified Dividend (1) Qualified Dividend Capital Gain Distribution1/15/2025 1/30/2025 $0.390625 $0.174871 $0.215754 $0.004/15/2025 4/30/2025 0.390625 0.174871 0.215754 0.007/15/2025 7/30/2025 0.390625 0.174871 0.215754 0.0010/15/2025 10/30/2025 0.390625 0.174871 0.215754 0.00    $1.562500 $0.699485 $0.863015 $0.00            The 2025 taxable distributions with respect to our 6.25% Series F Fixed to Floating Cumulative Redeemable Preferred Stock traded under ticker symbol ABR-PF are summarized as follows:

           6.25% Series F Fixed-to-Floating Cumulative Redeemable Preferred Stock (CUSIP #038923850)Record Date Payment Date Total Distribution Per Share Non-Qualified Dividend (1) Qualified Dividend Capital Gain Distribution1/15/2025 1/30/2025 $0.390625 $0.174871 $0.215754 $0.004/15/2025 4/30/2025 0.390625 0.174871 0.215754 0.007/15/2025 7/30/2025 0.390625 0.174871 0.215754 0.0010/15/2025 10/30/2025 0.390625 0.174871 0.215754 0.00    $1.562500 $0.699485 $0.863015 $0.00           (1) May be eligible for the 20% qualified business income deduction applicable to certain REIT dividends under IRC Section 199A(b)(1)(B).            For shareholders that may be required to report excess inclusion income to the Internal Revenue Service, we are pleased to report that in 2025, we will not pass through any excess inclusion income to our shareholders. As a result, no portion of the 2025 dividends should be treated as excess inclusion income for federal income tax purposes.

We do not issue K-1s to holders of our common and preferred stock. Please contact your financial advisor or broker to obtain information on a 1099 form.

Note: Shareholders are encouraged to consult with their tax advisors as to their specific tax treatment of our dividend distributions.

About Arbor Realty Trust, Inc.

Arbor Realty Trust, Inc. (NYSE: ABR) is a nationwide real estate investment trust and direct lender, providing loan origination and servicing for multifamily, single-family rental (SFR) portfolios, and other diverse commercial real estate assets. Headquartered in New York, Arbor manages a multibillion-dollar servicing portfolio, specializing in government-sponsored enterprise products. Arbor is a leading Fannie Mae DUS® lender and Freddie Mac Optigo® Seller/Servicer, and an approved FHA Multifamily Accelerated Processing (MAP) lender. Arbor’s product platform also includes bridge, CMBS, mezzanine and preferred equity loans. Rated by Standard and Poor’s and Fitch Ratings, Arbor is committed to building on its reputation for service, quality and customized solutions with an unparalleled dedication to providing our clients excellence over the entire life of a loan.

Safe Harbor Statement

Certain items in this press release may constitute forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations and beliefs and are subject to a number of trends and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Arbor can give no assurance that its expectations will be attained. Factors that could cause actual results to differ materially from Arbor’s expectations include, but are not limited to, changes in economic conditions generally, and the real estate markets specifically, continued ability to source new investments, changes in interest rates and/or credit spreads, and other risks detailed in Arbor’s Annual Report on Form 10-K for the year ended December 31, 2024 and its other reports filed with the SEC. Such forward-looking statements speak only as of the date of this press release. Arbor expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Arbor’s expectations with regard thereto or change in events, conditions, or circumstances on which any such statement is based.

Contact:
Arbor Realty Trust, Inc.
Investor Relations
516-506-4200
[email protected]

MIAMI, FL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lafayette Digital Acquisition Corp. I (Nasdaq: ZKPU) (the “Company”) today announced that, commencing February 4, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units.

No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on The Nasdaq Global Market under the symbols “ZKP” and “ZKPW,” respectively. Those units not separated will continue to trade on The Nasdaq Global Market under the symbol “ZKPU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

The offering of the units was made only by means of a prospectus, copies of which may be obtained from BTIG, LLC, 65 East 55th Street, New York, New York 10022, Attn: Syndicate Department, or by email at [email protected]. A registration statement on Form S-1 (333-290473) relating to these securities has been filed with the Securities and Exchange Commission (“SEC”) and was declared effective on January 8, 2026. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Lafayette Digital Acquisition Corp. I

Lafayette Digital Acquisition Corp. I is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination in any sector, the Company will primarily focus on target businesses in the technology industry. The Company’s management team is led by Samuel A. Jernigan IV, its Chief Executive Officer and Chairman of the Board of Directors.

Cautionary Note Concerning Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the registration statement and the prospectus filed in connection with the initial public offering with the SEC. Copies are available on the SEC’s website, www.sec.gov.

Contact Information

Samuel A. Jernigan IV
Chief Executive Officer
[email protected]

, /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, today announced that the Company received a letter from the Nasdaq Listing Qualifications (the "Letter"), indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

Further, the Nasdaq Listing Rules also provide the Company a compliance period of 180 calendar days to regain compliance. According to the Letter, the Company has from January 29, 2026, or until July 28, 2026, to regain compliance with the minimum bid price requirement. The Company can regain compliance, if at any time during this 180 day period, the closing bid price of its ordinary shares is at least $1 for a minimum of ten consecutive business days, in which case the Company will be provided with a written confirmation of compliance and this matter will be closed. In the event the Company does not regain compliance after the initial 180-day period, the Company may then be eligible for an additional time if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period.

If the Company cannot demonstrate compliance by the end of the 180-day period, the Nasdaq's staff will notify the Company that its ordinary shares are subject to delisting.

The Letter has no immediate effect on the Company's Nasdaq listing or the trading of its ordinary shares, and during the grace period, as may be extended, Galmed's ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol "GLMD".

About Galmed Pharmaceuticals Ltd.

We are a biopharmaceutical company focused on the development of Aramchol. We have focused almost exclusively on developing Aramchol for the treatment of liver diseases, and continue to actively advance Aramchol for the treatment of combination therapy for NASH. We are also seeking to develop Aramchol for certain oncological indications outside of NASH and fibrosis. In addition, as part of our growth strategy, we are actively pursuing opportunities to expand and diversify our product pipeline specifically targeting cardiometabolic indications and other innovative product candidates that align with our core expertise in drug development.

Forward-Looking Statements

Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. For example, the Company is using forward-looking statements when it discusses regaining compliance with Nasdaq's continued listing requirements, and timing and effect thereof. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to the potential synergistic effect of Aramchol, Stivarga® and Metformin as a new fixed-dose combination treatment, the expected timing of clinical trials, future clinical development and creating value for investors and stakeholders. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the development and approval of the use of Aramchol or any other product candidate for indications outside of non-alcoholic steatohepatitis, or NASH, also known as metabolic dysfunction-associated steatohepatitis, or MASH, and fibrosis or in combination therapy; the timing and cost of any pre-clinical or clinical trials of Aramchol or any other product candidate we develop; completion and receiving favorable results of any pre-clinical or clinical trial; regulatory action with respect to Aramchol or any other product candidate by the U.S. Food and Drug Administration, or the FDA, or the European Medicines Authority, or EMA, including but not limited to acceptance of an application for marketing authorization, review and approval of such application, and, if approved, the scope of the approved indication and labeling; the commercial launch and future sales of Aramchol and any future product candidates; our ability to comply with all applicable post-market regulatory requirements for Aramchol, or any other product candidate in the countries in which we seek to market the product; our ability to achieve favorable pricing for Aramchol, or any other product candidate; third-party payor reimbursement for Aramchol, or any other product candidate; our estimates regarding anticipated capital requirements and our needs for additional financing; market adoption of Aramchol or any other product candidate by physicians and patients; the timing, cost or other aspects of the commercial launch of Aramchol or any other product candidate; our ability to obtain and maintain adequate protection of our intellectual property; the possibility that we may face third-party claims of intellectual property infringement; our ability to manufacture our product candidates in commercial quantities, at an adequate quality or at an acceptable cost; our ability to establish adequate sales, marketing and distribution channels; intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; our expectations regarding licensing, acquisitions and strategic operations; current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk; our ability to maintain the listing of our ordinary shares on The Nasdaq Capital Market; the security, political and economic instability in the Middle East that could harm our business, including due to the current security situation in Israel, risks relating to our digital asset management strategy, including the highly volatile nature of the price of cryptocurrencies and other digital assets, the risk that our share price may be highly correlated to the price of the cryptocurrencies and other digital assets that we may hold, risks related to increased competition in the industries in which we do and will operate, risks relating to significant legal, commercial, regulatory and technical uncertainty regarding cryptocurrencies and other digital assets generally, risks relating to the treatment of crypto assets for U.S. and foreign tax purposes and those risks and uncertainties identified in Exhibit 99.2 to our Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission ("SEC") on August 25, 2025. We believe these forward-looking statements are reasonable; however, these statements are only current predictions and are subject to known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking statements. We discuss many of these risks in our Annual Report on Form 20-F for the year ended December 31, 2024, filed with the SEC on April 2, 2025 in greater detail under the heading "Risk Factors." Given these uncertainties, you should not rely upon forward-looking statements as predictions of future events. All forward-looking statements attributable to us or persons acting on our behalf speak only as of the date hereof and are expressly qualified in their entirety by the cautionary statements included in this report. We undertake no obligations to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. In evaluating forward-looking statements, you should consider these risks and uncertainties.

Logo - https://mma.prnewswire.com/media/1713483/Galmed_Pharmaceuticals_Logo.jpg

SOURCE Galmed Pharmaceuticals Ltd.

, /PRNewswire/ -- The Trustees of North European Oil Royalty Trust (NYSE-NRT) announced today a quarterly distribution of $0.22 per unit for the first quarter of fiscal 2026, payable on February 25, 2026 to owners of record on February 13, 2026.  This compares to a distribution of $0.04 per unit for the first quarter of fiscal 2025.

In accordance with the agreements between the Trust and the operating companies, the Trust's monthly scheduled royalty payments are paid based on the amount of royalties that were payable to the Trust in the prior calendar quarter.  Adjustments to the scheduled payments occur when scheduled payments differ from actual results. The significant increase in the year-over-year first quarter distribution results primarily from the lack of negative adjustments. The remaining balance of the negative adjustments from calendar 2023 totaling $1,754,661 impacted the 2025 first quarter distribution.  For the first quarter of fiscal 2026, there were positive end-of-quarter adjustments of $30,820 and $51,072 and a positive Mobil sulfur payment of $79,183. Further details will be available in the 10-Q scheduled to be released on or about February 27, 2026.

The cumulative 12-month distribution, which includes the January 2026 distribution and the three prior quarterly distributions, is $0.99 per unit. This 12-month cumulative distribution is 111%, or $0.52 per unit, higher than the prior 12-month distribution of $0.47 per unit.  The Trust makes quarterly distributions to unit owners during the months of February, May, August, and November.

Contact – Nancy J. Floyd Prue, Managing Trustee, telephone: (732) 741-4008, email: [email protected]. The Trust's press releases and other pertinent information are available on the Trust's website: www.neort.com.

Forward-Looking Statements

This press release may contain forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements address future expectations and events or conditions concerning the Trust, such as statements concerning future gas prices, royalty payments, and cash distributions. Many of these statements are based on information provided to the Trust by the operating companies or by consultants using public information sources, are difficult to predict, and are generally beyond the control of the Trust.  These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements. These include: the fact that the assets of the Trust are depleting assets and, if the operators developing the concession do not perform additional development projects, the assets may deplete faster than expected; risks and uncertainties concerning levels of gas production and gas sale prices, general economic conditions, and currency exchange rates; the ability or willingness of the operating companies to perform under their contractual obligations with the Trust; potential disputes with the operating companies and the resolution thereof; and political and economic uncertainty arising from Russia's invasion of Ukraine.  Any forward-looking statement speaks only as of the date on which such statement is made, and the Trust does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.

SOURCE North European Oil Royalty Trust

ISELIN, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Middlesex Water Company (NASDAQ: MSEX) today announced that its subsidiary, Tidewater Utilities, Inc. (TUI), has completed the acquisition of the water system assets serving 360 customers in Pinewood Acres in Delaware.

“We are pleased to welcome Pinewood Acres residents into the Tidewater family,” said Bruce E. Patrick, President of TUI. “A smooth and transparent transition for our new Pinewood Acres customers is our top priority. Our team remains dedicated to delivering safe and reliable water service and to continue our long tradition of being strong partners to the communities we serve.”

Approval for the acquisition was granted by the Delaware Public Service Commission, authorizing TUI to become the owner and operator of the Pinewood Acres water utility assets.

“Partnering with Tidewater Utilities allows Pinewood Acres residents to enjoy the continued reliability and long-term performance of the water system with the benefit of consistent regulatory oversight, expanded customer service options, and the expertise of a long-standing Delaware water provider,” said Pinewood Acres Management. “We are confident this transition will help support the community’s long-term water needs.”

Pinewood Acres customers will receive additional information from TUI by mail in the coming weeks. Resources and updates will also be available at www.TUIWater.com.

About Tidewater Utilities, Inc.

Tidewater Utilities, Inc. (“Tidewater”), a wholly owned subsidiary of Middlesex Water Company, is celebrating over 60 years of service to Delawareans. Tidewater is the largest private water supplier south of the Chesapeake & Delaware Canal, operating 172 active wells and 85 water treatment facilities serving approximately 62,000 customers across more than 480 communities in New Castle, Kent, and Sussex counties.

About Middlesex Water Company

Middlesex Water Company (“Middlesex”) (NASDAQ: MSEX) is one of the nation’s leading investor-owned water and wastewater utilities. Founded in 1897, Middlesex provides essential water and wastewater services to more than half a million people in New Jersey and Delaware. The company is committed to operational excellence, superior customer experience, responsible infrastructure investment, and sustainable, strategic growth.

Media Contact:
Brian Hague, Vice President of Communications & Corporate Affairs
[email protected]
(732) 638-7549

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2026) - Questcorp Mining Inc. (CSE: QQQ) (OTCQB: QQCMF) (FSE: D910) (the "Company" or "Questcorp") advises that as a result of a review by the British Columbia Securities Commission, the Company is issuing the following news release to clarify its disclosure.

On October 24, 2025, the Company completed a non-brokered private placement (the "Offering") in which it issued 14,000,334 units (each, a "Unit") at a price of $0.15 per Unit for gross proceeds of $2,100,050. Concurrent with the Offering, the Company entered into a sharing agreement with a notional amount of $2,000,000 with an institutional investor, Sorbie Bornholm LP ("Sorbie") and the Company (the "Sharing Agreement").

The Sharing Agreement provides that the Company will receive an initial release of $85,000, after which the Company's total payoff will be determined through twenty-four monthly settlement tranches, measured against the benchmark price as defined in the news release issued by the Company on November 10, 2025. As a result, the Company may ultimately receive more or materially less than the original proceeds of $2,000,000. The final amount received will depend on the Company's future share price, which is subject to market fluctuations and may vary over time. Accordingly, there is no assurance as to the total amount the Company will receive under the Sharing Agreement.

The Company also wishes to clarify that no funds under the Sharing Agreement are held in escrow or otherwise secured. Accordingly, if Sorbie were to experience adverse financial circumstances, the Company may be exposed to significant risk, as shares have been issued and there can be no assurance that the anticipated payments under the Sharing Agreement will be fully received.

About Questcorp Mining Inc.
Questcorp Mining Inc. is engaged in the business of the acquisition and exploration of mineral properties in North America, with the objective of locating and developing economic precious and base metals properties of merit. The Company holds an option to acquire an undivided 100% interest in and to mineral claims totaling 1,168.09 hectares comprising the North Island Copper Property, on Vancouver Island, British Columbia, subject to a royalty obligation. The Company also holds an option to acquire an undivided 100% interest in and to mineral claims totaling 2,520.2 hectares comprising the La Union Project located in Sonora, Mexico, subject to a royalty obligation.

This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties, uncertain capital markets; and delay or failure to receive board or regulatory approvals. There can be no assurance that the geophysical surveys will be completed as contemplated or at all and that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282248

Source: Questcorp Mining Inc.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

The Norway sovereign wealth fund increased its BTC holdings to 9,573 BTC in 2025, representing a 149% surge in overall exposure. Data from research firm K33 shows that the company does not have any direct Bitcoin holdings but does hold significant shares in crypto companies such as Coinbase and Strategy.

The Norway sovereign wealth fund saw its indirect Bitcoin exposure rise to 9,573 BTC, representing a 149% rise in 2025, according to data from research firm K33. The fund’s total indirect BTC exposure at the end of 2024 stood at 3,839 BTC, implying the firm increased its BTC exposure by 5,734 BTC over the year. 

K33 Research says NBIM’s indirect BTC exposure sits at an $837M valuation Once again, back on duty to cover the indirect BTC ownership of the world's largest sovereign wealth fund, Norway's Oil Fund.

While BTC price action has been horrendous for a while, NBIM's indirect BTC exposure marches higher. It grew by 149% in 2025 to 9,573 BTC. pic.twitter.com/zOIeQYqDx3

— Vetle Lunde (@VetleLunde) January 30, 2026

The K33 data shows that the wealth fund does not hold Bitcoin on its books. Instead, it owns a significant stake in crypto companies such as Coinbase, Strategy, Block, Metaplanet, and MARA. K33’s Head of Research, Vetle Lunde, reported that “NBIM held 8.5 billion NOK in indirect BTC exposure by EOY 2025, or $837 million USD” despite Bitcoin’s recent decline.

Norway’s central bank controls the investment activities of the country’s sovereign wealth fund, the Government Pension Fund Global. The management services are provided by the central bank’s subsidiary, Norges Bank Investment Management (NBIM), which Cryptopolitan reported operates as a separate unit within the central bank under the direction of the Norwegian Ministry of Finance. The fund is one of the world’s most significant sovereign wealth funds, with over $2 trillion in assets under management, primarily invested in bonds, global equities, and real estate.  

Lunde noted that the actual weighting of NBIM’s indirect Bitcoin exposure remains unchanged from H1 2025, with slightly less than 0.04% of the fund’s assets tied to BTC-linked holdings across the past two reporting periods. He highlighted that the exposure indicates a “deliberate weighting.” Lunde noted that K33 research did not find any company holdings by the fund whose digital crypto treasury has other digital currencies.

“My motivation for monitoring NBIM’s indirect BTC exposure is to highlight how BTC is finding its way into any well-diversified portfolio, deliberate or not. While short-term price action sucks, the growth trend highlights the strong underlying institutional adoption of BTC.”

–Vetle Lunde, Head of Research at K33.

Lunde’s previous NBIM indirect Bitcoin exposure update came in August 2025, when the researcher revealed that the fund’s exposure had reached an all-time high of 7,161 BTC. A Cryptopolitan coverage reported that the wealth fund had increased its Bitcoin exposure by 87.7% in just six months. The coverage highlighted that NBIM’s BTC exposure had surged significantly in the preceding 5 years as treasury companies like Strategy doubled down on Bitcoin holdings. Strategy is the world’s largest corporate holder of BTC, with over 712,647 Bitcoin worth $58.96 billion at the time of this publication.

Norway’s sovereign wealth fund supports MetaPlanet’s management proposals On December 17, 2025, the Norwegian wealth fund announced that it will support five of Metaplanet’s proposals during its special meeting on December 22. Cryptopolitan reported that the public announcement from the $2 trillion fund sent Metaplanet’s stock rallying. Metaplanet’s director for Bitcoin Strategy, Dylan LeClair, said that the wealth fund was confident in Metaplanet’s strategy of accumulating Bitcoin. 

The report also highlighted that the fund backed the firm’s proposal to amend Articles to increase Authorized Capital for Class A and B Shares. The BTC treasury firm already surpassed its target of accumulating 21,000 Bitcoin by 2026 and now holds 35,102 Bitcoin worth approximately 2.92 billion at current BTC prices, according to data from Bitcoin Treasuries. The Japanese company is the fourth-largest corporate BTC holder after Strategy, MARA Holdings, and Twenty One Capital.

The smartest crypto minds already read our newsletter. Want in? Join them.

Bitcoin briefly stabilized near $83,000 after a flash crash to $81,314 wiped out $1.7 billion in leveraged positions. The crash dragged its market cap down to $1.62 trillion before a modest rebound.

DOGE gained 1.86% over the last 24 hours, trading near $0.12. Influencer forecasts $0.14 breakout while TradingView indicators flash bearish signals.

Newton Gitonga2 min read

30 January 2026, 07:30 PM

Dogecoin has gained 1.86% over the last 24 hours, trading around $0.1171 at the time of writing. DOGE has, however, dropped 6.93% in the past week. The digital asset has struggled to maintain stability, hovering around $0.12 while briefly falling to $0.11 during the downward move.

Influencer Predictions Spark OptimismKamran Asghar, a well-known figure in cryptocurrency circles, recently shared his outlook on Dogecoin's potential trajectory. His analysis of X highlighted what he views as a coiling pattern in the price structure. The influencer believes this tight consolidation phase could precede a breakout movement.

Asghar's projection points to a near-term climb toward $0.14. This forecast has generated discussion among traders and investors monitoring the meme coin's performance. The prediction represents a notable increase from current levels, suggesting room for upward momentum if market conditions align favorably.

Such optimistic projections often attract attention in the volatile cryptocurrency market. Traders frequently look to technical patterns and consolidation phases as indicators of impending price movements. The tight range Asghar identified could signal accumulation before a directional break.

Technical Indicators Paint a Different PictureContrasting perspectives emerge from the technical analysis tools available on TradingView. Multiple indicators currently signal a warning for Dogecoin holders. The Awesome Oscillator has generated a sell signal, pointing to potential weakness in the current price structure.

The momentum indicator reinforces this cautious outlook. It too flashes sell signals, suggesting that downward pressure may dominate in the immediate future. These technical readings indicate that sellers currently hold more influence than buyers in the market.

The divergence between bullish predictions and bearish technical signals creates uncertainty. Selling pressure appears to be gaining strength based on standard momentum measurements. This dynamic could contribute to further price declines if the pattern continues.

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Newton Gitonga covers cryptocurrencies, blockchain, and digital finance. He specializes in breaking down complex trends with clear, data-driven reporting. His work focuses on market analysis, technical insights, and the evolving role of altcoins in shaping global markets.

Read more about

Dogecoin (DOGE) News

While most cryptocurrencies are under pressure, Canton (CC) has been rising steadily.

In the past week, the token surged more than 16%, hitting a new all-time high near $0.1813.

Canton price chart | Source: CoingeckoThis performance comes at a time when Bitcoin (BTC) has fallen 7.2%, and Ethereum has dropped by 6.2%, meaning Canton is charting its own course.

Institutional adoption drives real-world demand Copy link to section

A major factor behind CC’s resilience is institutional adoption.

Canton’s privacy-focused infrastructure is increasingly seen as essential for regulated asset tokenisation.

Partnerships with heavyweights like JPMorgan and The Depository Trust & Clearing Corporation (DTCC) are adding credibility.

JPMorgan has expanded its JPM Coin integration on the Canton network, creating additional settlement demand.

Meanwhile, DTCC’s pilot program for tokenised US Treasuries positions Canton as a hub for real-world assets.

Daily settlement volumes, such as $280 billion in repo markets, generate natural demand for CC.

Institutions are treating CC not as a speculative play but as infrastructure critical for regulated financial activity.

The token’s rise aligns with this growing real-world utility.

Investors are closely watching updates from the DTCC pilot, which could further boost adoption in the first half of 2026.

Technical strength and market decoupling Copy link to section

Canton’s technical structure is equally compelling.

The token has broken above the 0.786 Fibonacci retracement level at $0.155.

It continues to trade near its all-time high, reflecting strong upward momentum.

The 7-day RSI currently sits at 76.3, signalling overbought conditions, but also confirming bullish strength.

Low liquidity amplifies price movements, allowing CC to surge even in a weak market.

Support zones to watch include $0.155 and $0.17.

If these levels hold, CC could target $0.20–$0.22 in the near term.

Another key factor is market decoupling.

While most crypto assets are sliding, CC’s gains are driven by its unique utility.

The token appeals to traders seeking stability amid macroeconomic uncertainty.

Social media buzz and retail enthusiasm have also contributed to its upward momentum.

Investors view CC as a hedge against broader crypto volatility.

Sustaining 24-hour volume above $45 million will be crucial to maintaining momentum.

Monitoring Bitcoin’s stability near $82K will also provide insight into potential market risks.

In a nutshell, Canton’s rally stems from a combination of institutional adoption, technical strength, and market decoupling.

The token’s focus on real-world assets gives it a fundamental edge over purely speculative projects.

While overbought conditions and low liquidity warrant caution, the long-term narrative remains bullish.

Canton is proving that it can thrive even when the broader crypto market struggles.

For investors seeking a blend of utility and momentum, CC is a token that could be worth watching, although it is important to keep in mind that digital assets are highly volatile and Canton is not exceptional.

Quick Links:

By

:

Published: Jan 30, 2026, 19:43 GMT+00:00

Key Points:Multiple financial assets crashed after President Donald Trump revealed his pick for the Federal Reserve.Kevin Warsh is a seasoned Fed governor who doesn’t seem to care much about digital assets.Today’s drop further confirmed our bearish scenario for Bitcoin (BTC) after a confirmed flag pattern.

The markets are reeling today after President Donald Trump revealed who he will appoint as the future head of the Federal Reserve. Bitcoin (BTC) is tumbling by nearly 6% after the head of state ushered in the name Kevin Warsh, causing cascade liquidations exceeding $1.2 billion.

Total Crypto Liquidations – Source: CoinGlass

President Trump is definitely getting better at crashing the markets every now and then, and has become traders’ most pressing concern.

Everybody is getting used to tiptoe in their positions whenever he prepares to talk. The problem is, he doesn’t always give the market a heads up.

Gold and silver have crashed as well, with staggering single-day losses of 10% and 30% respectively.

Who is Kevin Warsh and Why Should Cryptos Care? Market participants fear that Warsh might not be as “moderate” as the Fed’s long-tenured current Chairman, Jerome Powell.

In addition, growing concerns of a “politicized” Fed may have been responsible for pushing asset prices to lower levels, as Warsh was, at some point, on Trump’s list of potential candidates for the Treasury Department.

Trump’s increasingly hostile rhetoric against Powell signaled that he won’t reappoint the Fed’s current leader, primarily because he has been reluctant to lower interest rates any further despite the President’s continuous pressure.

That said, Warsh is no wild card. He became the youngest Fed governor at 35 and served right next to Ben Bernanke. He advised Bernanke during the 2008 financial crisis and knows the ins and outs of the U.S. financial markets like few.

Warsh is considered pro-crypto. He was quoted in a conversation with Stanley Druckenmiller, a successful American investor, saying: “[Bitcoin] It’s just the newest, coolest software that will provide us the opportunity to do things we could never have done before.”

In any case, whether he is a pro-crypto figure or not doesn’t really matter, as the Fed does not deal with specific asset classes.

What the market seems to be reacting to is an unexpected change in a key leadership role that will shape the future of the country’s financial system for many years. Sell first, analyze later.

Sell Signals Stack Up in the 4H Chart – $74K Next? Trading volumes for BTC have gone up by 20% in the past 24 hours, climbing to 4% of the asset’s circulating market. Surprisingly, today is still not at all one of the worst days that traders have faced lately.

With $1.2 billion in long positions being wiped out in a matter of minutes, today’s mini flash crash does not make it to the top of the crypto market’s worst days.

BTC/USD 4H Chart (Binance) – Source: TradingView

Sell signals have been stacking up in the 4-hour chart. Yesterday, we warned that a bear flag pattern had been confirmed. Our bearish target for BTC at the time is $74,000, meaning a 12% downside risk.

The sell-off accelerated as the price dropped below a price channel that was starting to form in this lower time frame. Now, BTC is heading to retest the lower bound of this setup. A rejection of this line will likely confirm that the token is heading to lower lows.

The top crypto seems to have encountered strong support at its November 21 lows of $81,000, making this a short-term target if bearish momentum resumes.

That said, the Relative Strength Index (RSI) just hit oversold, increasing the odds of a technical bounce. Interestingly, a bullish divergence has popped up, also favoring a potential reversal.

However, the baseline scenario remains bearish as the market may need more time to adjust its scenarios to the latest news. Sellers will keep selling until they think it’s cheap.

So, buckle up. This could be an ugly ride.

Related Articles

XRP News Today: Funding Rates Turn “Deep Red” as XRP Loses Key Support – $1.65 Next?Ethereum Price Forecast: ETH Eyes $1.5K As Microsoft Dampens AI Revolution SentimentBitcoin Price Forecast: BTC Eyes $70K as Fed Rate Cut Hopes Fade on Warsh BuzzAbout the Author

Alejandro Arrieche specializes in drafting news articles that incorporate technical analysis for traders and possesses in-depth knowledge of value investing and fundamental analysis.

Editors’ Picks

NASDAQ Index, SP500, Dow Jones Forecasts – Stocks Retreat Amid Crash In Silver Markets

Gold (XAUUSD), Silver, Platinum Forecasts – Silver Collapses 18% As Traders Rush For Exits

Silver (XAG) Forecast: Silver Market Eyes 50-Day MA at $74.55 for Possible Momentum Shift

Natural Gas News: Weather Forecast Through Mid-Feb Could Push Futures to $4.81

Silver Price Forecast: A February Pause Sets Up a Final Surge into May